CEL-SCI, GlycoGenesys and Thinkpath Death Spiral
No ratings
CEL-SCI, GlycoGenesys and Thinkpath's Death Spiral. Although there's not much public news popping on CEL-SCI (AMEX: CVM) at the moment, the technical picture looks intriguing. At 70-ish cents, the shares have retraced 50 percent from the low in March 2003